US Patent 9670221 Furopyridines as bromodomain inhibitors
Patent 9670221 was granted and assigned to GlaxoSmithKline on June, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+147 characters)
Article
Patent abstract
The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Infobox
Patent Inventor Names
Christopher Roland Wellaway0
Dominique Amans0
John Alexander Brown0
Matthew Campbell0
Matthew J. Lindon0
Michael David Barker0
Natalie Hope Theodoulou0
Neil Stuart Garton0
Paul Bamborough0
Rino Antonio Bit0
Susan Marie Westaway0
Tracy Jane Shipley0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09670221 Furopyridines as bromodomain inhibitors US Patent 9670221 Furopyridines as bromodomain inhibitors
Infobox
Patent Number
096702210
Patent Number
96702210
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
096702210
Date of Patent
June 6, 2017
0Patent Application Number
147709220
Date Filed
March 12, 2014
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09670221 Furopyridines as bromodomain inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09670221
Date of patent
June 6, 2017
Patent application number
14770922
Date Filed
March 12, 2014
Patent primary examiner
Find more entities like US Patent 9670221 Furopyridines as bromodomain inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
